Get the Stockscreener App
2.4158
1.26%
0.0258
Tuhura Biosciences Inc stock is traded at $2.4158, with a volume of 44,793.
It is up +1.26% in the last 24 hours and down -3.20% over the past month.
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.
See More
Previous Close:
$2.39
Open:
$2.44
24h Volume:
44,793
Relative Volume:
0.11
Market Cap:
$122.14M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-2.81%
1M Performance:
-3.20%
6M Performance:
-42.65%
1Y Performance:
+0.00%
1-Day Range:
$2.37
$2.44
1-Week Range:
$2.37
$2.65
52-Week Range:
$1.80
$7.20
Tuhura Biosciences Inc Stock (HURA) Company Profile
Name
Tuhura Biosciences Inc
Sector
Industry
Phone
813-875-6600
Address
10500 UNIVERSITY CENTER DR., TAMPA
Compare HURA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HURA
Tuhura Biosciences Inc
|
2.43 | 122.14M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.42 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.45 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.17 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.67 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
326.40 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Tuhura Biosciences Inc Stock (HURA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-03-25 | Initiated | H.C. Wainwright | Buy |
| Dec-19-24 | Initiated | Rodman & Renshaw | Buy |
| Nov-05-24 | Initiated | Maxim Group | Buy |
Tuhura Biosciences Inc Stock (HURA) Latest News
Is TuHURA Biosciences Inc. stock gaining market shareJuly 2025 PreEarnings & Verified Technical Trade Signals - newser.com
What data driven models say about TuHURA Biosciences Inc.’s future2025 Technical Patterns & Entry and Exit Point Strategies - newser.com
Is TuHURA Biosciences Inc. stock affected by interest rate hikesRate Hike & Growth Oriented Trading Recommendations - newser.com
Analyzing recovery setups for TuHURA Biosciences Inc. investorsStop Loss & Precise Swing Trade Alerts - newser.com
Can a trend reversal in TuHURA Biosciences Inc. lead to recoveryPortfolio Risk Summary & Risk Controlled Daily Trade Plans - newser.com
Can TuHURA Biosciences Inc. (PL3) stock retain market dominanceTrade Volume Report & Low Risk High Reward Ideas - newser.com
Momentum divergence signals in TuHURA Biosciences Inc. chartQuarterly Portfolio Review & Low Risk High Win Rate Picks - newser.com
Can TuHURA Biosciences Inc. hit a new high this monthWeekly Profit Summary & Weekly High Conviction Trade Ideas - newser.com
Using data filters to optimize entry into TuHURA Biosciences Inc.Gold Moves & AI Forecast Swing Trade Picks - newser.com
TuHURA Biosciences' (HURA) "Sell (E+)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Will TuHURA Biosciences Inc. (PL3) stock hit analyst forecastsTrade Signal Summary & Safe Capital Investment Plans - newser.com
Best data tools to analyze TuHURA Biosciences Inc. stockJuly 2025 Spike Watch & Long-Term Investment Growth Plans - newser.com
Combining price and volume data for TuHURA Biosciences Inc.Earnings Growth Report & Precise Swing Trade Entry Alerts - newser.com
Will TuHURA Biosciences Inc. (PL3) stock draw ESG focused funds2025 Earnings Surprises & Real-Time Volume Trigger Notifications - newser.com
Will TuHURA Biosciences Inc. benefit from macro trendsWeekly Gains Summary & Fast Exit and Entry Trade Guides - newser.com
What high frequency data says about TuHURA Biosciences Inc.2025 Year in Review & Reliable Entry Point Trade Alerts - newser.com
Can TuHURA Biosciences Inc. rally from current levelsTrade Risk Summary & Reliable Entry Point Trade Alerts - newser.com
TuHURA Biosciences, Inc. (NASDAQ:HURA) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
TuHURA Biosciences, Inc. (NASDAQ:HURA) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Tuhura Biosciences Inc Stock (HURA) Financials Data
There is no financial data for Tuhura Biosciences Inc (HURA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
2.20%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):